IP Verse

Composition Containing Eugenol As Active Ingredient For Preventing Or Treating Atopic Dermatitis

PatentPatent Analysis

EP3061448

MEDICAL XYNAPSE
Application Number
EP14854980A
Filing Date
Oct 24, 2014
Status
Revoked
Nov 11, 2022
Grant Date
Jul 29, 2020
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3061448B1 was granted to Medical Xynapse on Jul 29, 2020 following the initial filing on Oct 24, 2014 under the application number EP14854980A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BEIERSDORFApr 27, 2021ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents